EN

Translate:

Interested in supplying us with spore products Email: Mark@SporeBuddies.com

The Beckley Foundation Microdose Study

Are you currently, or are planning to, microdose with a psychedelic? We are now recruiting for our new psychedelic microdosing study!


The Beckley/Imperial Psychedelic Reasearch Programme is excited to announce a new, self-blinded study on psycedelic microdosing.


Sign up for their News Letter HERE. Volunteer request will be announced via the news letter. 

If you would like to have a look around their site click HERE

From the Beckley Foundation Site

 

Our research with Psilocybin

In 2016, the Beckley/Imperial Research Programme released a study that revealed the staggering potential of psilocybin to alleviate treatment-resistant depression, with 67 percent being depression free after one week and 42 percent remaining in remission three months later. Collaborating with highly prestigious universities, the Beckley Foundation has also conducted research indicating the efficacy of psilocybin as an aid to smoking cessation. Using the latest brain-imaging techniques, we have shed some light on how psilocybin may produce its therapeutic effects, by generating a more ‘entropic’ pattern of brain connectivity, with increased communication throughout the brain leading to more flexible modes of cognition.

Psilocybin for Depression

image2

Read me  

Just click back to return to our site

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

image3

Read me

Just click back to return to our site

Support Psychedelic Reasearch & Drug Policy reform with Donation to the Beckley Foundation

image4

Read me 

Just click back to return to our site